Ep 4 receptor-associated protein regulates gluconeogenesis in the liver and is associated with hyperglycemia in diabetic mice

Sei Higuchi, Risako Fujikawa, Masato Nakatsuji, Mika Yasui, Taichi Ikedo, Manabu Nagata, Kenji Mishima, Keiichi Irie, Michihiro Matsumoto, Masayuki Yokode, Manabu Minami

Research output: Contribution to journalArticle

Abstract

Prostaglandin E 2 receptor 4 –associated protein (EPRAP) is a key molecule in suppressing inflammatory responses in macrophages. EPRAP is expressed not only in macrophages but also in hepatocytes; however, the role of EPRAP in hepatocytes has not yet been defined. To examine the physiological role of hepatic EPRAP in mice, we performed the glucose tolerance test and the hyperinsulinemic-euglycemic clamp in high-fat sucrose diet (HFSD)-fed wild-type (WT) and Eprap null mice. We evaluated the contribution of EPRAP to gluconeogenesis by pyruvate tolerance test and primary hepatocyte experiments. Furthermore, lentivirus-expressing Eprap-specific small-hairpin RNA was injected in db/db mice. HFSD-fed Eprap null mice had significantly lower blood glucose levels than HFSD-fed WT mice. Eprap null mice also had low glucose levels after fasting or pyruvic acid injection. Moreover, primary hepatocytes from Eprap-deficient mice showed decreased glucose production and lower expression of the Phosphoe-nolpyruvate carboxykinase and Glucose 6-phosphatase genes. Lenti-virus-mediated hepatic Eprap suppression decreased glucose levels and the expression of gluconeogenic genes in db/db mice. We conclude that EPRAP regulates gluconeogenesis in hepatocytes and is associated with hyperglycemia in diabetic mice. Our data suggest that suppression of EPRAP could be a novel strategy for the treatment of diabetes.

Original languageEnglish
Pages (from-to)E410-E417
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume316
Issue number3
DOIs
Publication statusPublished - Mar 1 2019
Externally publishedYes

Fingerprint

Gluconeogenesis
Hyperglycemia
Liver
Hepatocytes
Proteins
High Fat Diet
Sucrose
Pyruvic Acid
Glucose
Receptors, Prostaglandin E, EP4 Subtype
Macrophages
Glucose-6-Phosphatase
Lentivirus
Glucose Clamp Technique
Glucose Tolerance Test
Small Interfering RNA
Blood Glucose
Fasting
Viruses
Gene Expression

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Cite this

Ep 4 receptor-associated protein regulates gluconeogenesis in the liver and is associated with hyperglycemia in diabetic mice . / Higuchi, Sei; Fujikawa, Risako; Nakatsuji, Masato; Yasui, Mika; Ikedo, Taichi; Nagata, Manabu; Mishima, Kenji; Irie, Keiichi; Matsumoto, Michihiro; Yokode, Masayuki; Minami, Manabu.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 316, No. 3, 01.03.2019, p. E410-E417.

Research output: Contribution to journalArticle

Higuchi, Sei ; Fujikawa, Risako ; Nakatsuji, Masato ; Yasui, Mika ; Ikedo, Taichi ; Nagata, Manabu ; Mishima, Kenji ; Irie, Keiichi ; Matsumoto, Michihiro ; Yokode, Masayuki ; Minami, Manabu. / Ep 4 receptor-associated protein regulates gluconeogenesis in the liver and is associated with hyperglycemia in diabetic mice In: American Journal of Physiology - Endocrinology and Metabolism. 2019 ; Vol. 316, No. 3. pp. E410-E417.
@article{66222b326ca64f06b245cdaed4501529,
title = "Ep 4 receptor-associated protein regulates gluconeogenesis in the liver and is associated with hyperglycemia in diabetic mice",
abstract = "Prostaglandin E 2 receptor 4 –associated protein (EPRAP) is a key molecule in suppressing inflammatory responses in macrophages. EPRAP is expressed not only in macrophages but also in hepatocytes; however, the role of EPRAP in hepatocytes has not yet been defined. To examine the physiological role of hepatic EPRAP in mice, we performed the glucose tolerance test and the hyperinsulinemic-euglycemic clamp in high-fat sucrose diet (HFSD)-fed wild-type (WT) and Eprap null mice. We evaluated the contribution of EPRAP to gluconeogenesis by pyruvate tolerance test and primary hepatocyte experiments. Furthermore, lentivirus-expressing Eprap-specific small-hairpin RNA was injected in db/db mice. HFSD-fed Eprap null mice had significantly lower blood glucose levels than HFSD-fed WT mice. Eprap null mice also had low glucose levels after fasting or pyruvic acid injection. Moreover, primary hepatocytes from Eprap-deficient mice showed decreased glucose production and lower expression of the Phosphoe-nolpyruvate carboxykinase and Glucose 6-phosphatase genes. Lenti-virus-mediated hepatic Eprap suppression decreased glucose levels and the expression of gluconeogenic genes in db/db mice. We conclude that EPRAP regulates gluconeogenesis in hepatocytes and is associated with hyperglycemia in diabetic mice. Our data suggest that suppression of EPRAP could be a novel strategy for the treatment of diabetes.",
author = "Sei Higuchi and Risako Fujikawa and Masato Nakatsuji and Mika Yasui and Taichi Ikedo and Manabu Nagata and Kenji Mishima and Keiichi Irie and Michihiro Matsumoto and Masayuki Yokode and Manabu Minami",
year = "2019",
month = "3",
day = "1",
doi = "10.1152/ajpendo.00035.2018",
language = "English",
volume = "316",
pages = "E410--E417",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Ep 4 receptor-associated protein regulates gluconeogenesis in the liver and is associated with hyperglycemia in diabetic mice

AU - Higuchi, Sei

AU - Fujikawa, Risako

AU - Nakatsuji, Masato

AU - Yasui, Mika

AU - Ikedo, Taichi

AU - Nagata, Manabu

AU - Mishima, Kenji

AU - Irie, Keiichi

AU - Matsumoto, Michihiro

AU - Yokode, Masayuki

AU - Minami, Manabu

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Prostaglandin E 2 receptor 4 –associated protein (EPRAP) is a key molecule in suppressing inflammatory responses in macrophages. EPRAP is expressed not only in macrophages but also in hepatocytes; however, the role of EPRAP in hepatocytes has not yet been defined. To examine the physiological role of hepatic EPRAP in mice, we performed the glucose tolerance test and the hyperinsulinemic-euglycemic clamp in high-fat sucrose diet (HFSD)-fed wild-type (WT) and Eprap null mice. We evaluated the contribution of EPRAP to gluconeogenesis by pyruvate tolerance test and primary hepatocyte experiments. Furthermore, lentivirus-expressing Eprap-specific small-hairpin RNA was injected in db/db mice. HFSD-fed Eprap null mice had significantly lower blood glucose levels than HFSD-fed WT mice. Eprap null mice also had low glucose levels after fasting or pyruvic acid injection. Moreover, primary hepatocytes from Eprap-deficient mice showed decreased glucose production and lower expression of the Phosphoe-nolpyruvate carboxykinase and Glucose 6-phosphatase genes. Lenti-virus-mediated hepatic Eprap suppression decreased glucose levels and the expression of gluconeogenic genes in db/db mice. We conclude that EPRAP regulates gluconeogenesis in hepatocytes and is associated with hyperglycemia in diabetic mice. Our data suggest that suppression of EPRAP could be a novel strategy for the treatment of diabetes.

AB - Prostaglandin E 2 receptor 4 –associated protein (EPRAP) is a key molecule in suppressing inflammatory responses in macrophages. EPRAP is expressed not only in macrophages but also in hepatocytes; however, the role of EPRAP in hepatocytes has not yet been defined. To examine the physiological role of hepatic EPRAP in mice, we performed the glucose tolerance test and the hyperinsulinemic-euglycemic clamp in high-fat sucrose diet (HFSD)-fed wild-type (WT) and Eprap null mice. We evaluated the contribution of EPRAP to gluconeogenesis by pyruvate tolerance test and primary hepatocyte experiments. Furthermore, lentivirus-expressing Eprap-specific small-hairpin RNA was injected in db/db mice. HFSD-fed Eprap null mice had significantly lower blood glucose levels than HFSD-fed WT mice. Eprap null mice also had low glucose levels after fasting or pyruvic acid injection. Moreover, primary hepatocytes from Eprap-deficient mice showed decreased glucose production and lower expression of the Phosphoe-nolpyruvate carboxykinase and Glucose 6-phosphatase genes. Lenti-virus-mediated hepatic Eprap suppression decreased glucose levels and the expression of gluconeogenic genes in db/db mice. We conclude that EPRAP regulates gluconeogenesis in hepatocytes and is associated with hyperglycemia in diabetic mice. Our data suggest that suppression of EPRAP could be a novel strategy for the treatment of diabetes.

UR - http://www.scopus.com/inward/record.url?scp=85062273609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062273609&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00035.2018

DO - 10.1152/ajpendo.00035.2018

M3 - Article

VL - 316

SP - E410-E417

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 3

ER -